author-photo

Anne Boulay

French Institute of Health and Medical Research

18

Papers

1469

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

A Phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson’s disease (PASADENA): rationale, design and baseline data

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (1)
Remote monitoring of progression in early Parkinson's disease: reliability and validity of the Roche PD Mobile Application v2

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (0)
mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor

2009 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (194)
Memo is a cofilin-interacting protein that influences PLCγ1 and cofilin activities, and is essential for maintaining directionality during ErbB2-induced tumor-cell migration

2009 Journal of Cell Science
Show All
- Source
- Cite
- Save
Citations (29)
Identifying Optimal Biologic Doses of Everolimus (RAD001) in Patients With Cancer Based on the Modeling of Preclinical and Clinical Pharmacokinetic and Pharmacodynamic Data

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (198)
Dual Inhibition of mTOR and Estrogen Receptor Signaling In vitro Induces Cell Death in Models of Breast Cancer

2005 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (314)
P53 natural as biomarker for treatment with mTOR inhibitors in combination with a cytotoxic agent

2005
Show All
- Source
- Cite
- Save
Citations (0)
Dosing and scheduling influence the antitumor efficacy of a phosphinic peptide inhibitor of matrix metalloproteinases.

2005 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (26)
Biomarqueurs pour la sensibilite de maladies proliferantes aux inhibiteurs mtor

2004
Show All
- Source
- Cite
- Save
Citations (0)
Antitumor Efficacy of Intermittent Treatment Schedules with the Rapamycin Derivative RAD001 Correlates with Prolonged Inactivation of Ribosomal Protein S6 Kinase 1 in Peripheral Blood Mononuclear Cells

2004 Cancer Research
Show All
- Source
- Cite
- Save
Citations (303)